CPH — Cipher Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- CA$339.41m
- CA$327.17m
- $50.45m
Brief: Cipher Pharmaceuticals says is working with advisor to consider strategic alternatives
Brief: Cipher appoints Stephen Lemieux as chief financial officer
Brief: Cipher Pharmaceuticals Q2 loss per share c$0.13
Brief: Cipher Pharmaceuticals announces changes to board of directors
Brief: Cipher pharmaceuticals sees Q2 total revenue of about $11.7 mln
Brief: Cipher Pharmaceuticals announces Ozenoxacin accepted for review by Health Canada
Brief: Cipher pharmaceuticals announces Ozenoxacin accepted for review by Health Canada
Brief: Cipher Pharma's Special committee responds to Early Warning Report filed by 1207407 Ontario Ltd
Brief: Cipher Pharmaceuticals Q1 net loss per basic share $0.10
Brief: Cipher Pharmaceuticals acquires worldwide rights to Dalhousie University's investigational tattoo removal cream
Brief: Cipher Pharmaceuticals announces retirement of CFO Norm Evans
Brief: Cipher Pharmaceuticals announces approvals of SD Cream and AD Cream
Brief: Cipher Pharmaceuticals announces Canadian launch of Beteflam
Brief: Cipher Pharmaceuticals reports Q4 earnings $0.08/shr
Brief: Cipher Pharma launches skin drug Actikerall in Canada
Brief: Cipher Pharmaceuticals says new drug submission for Sitavig accepted for review by Health Canada
Brief: Cipher says Health Canada has approved Beteflam
Brief: Cipher qtrly total revenue increased 28% to $8.5 mln
Brief: Cipher announces settlement in patent litigation for Absorica